Bio-Techne Introduces CE-SDS PLUS for Maurice™ System

MINNEAPOLIS /PRNewswire/ -- Bio-Techne today announced the launch of the CE-SDS PLUS system for its ProteinSimple-branded Maurice platform. This new system further expands the usability of Maurice's proprietary cartridge and reduces undesirable protein fragmentation during separation.

Since its introduction in 2016, Maurice has enabled capillary electrophoresis - sodium dodecyl sulfate (CE-SDS) for size-based separation across a broad range of molecules. The CE-SDS PLUS system includes a new cartridge, a novel sample buffer, and a new version of 'Compass for iCE' software. These advances will enable researchers to obtain superior data consistency, significantly increased injection number per cartridge, and a more accurate analysis of proteins susceptible to fragmentation. In addition, the gold-standard, 'whole-column' imaging technology Maurice employs is augmented with an additional fluorescence filter for broader applications in charge heterogeneity analysis.

Dave Eansor, President of Bio-Techne's Protein Sciences Segment, commented, "We continue to develop robust tools that simplify applications and remove complexity, enabling researchers to focus on their science. Maurice brings a new level of data reproducibility and ease-of-use to the CE market. We are excited to introduce CE-SDS PLUS to our customers for further enhancement of size-based characterization and purity analysis."


Maurice CE-SDS PLUS will be unveiled at WCBP 2019, which is being held January 29-31, 2019, in Washington, D.C.USA. Learn more about the Maurice system at www.proteinsimple.com/maurice.

 

Contact: Dave Eansor, President, Protein Sciences Segment, 612-379-2956

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Bio-Techne Corporation

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. Bio-Techne's portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, offering researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers as well as clinical research laboratories and constitute the Protein Sciences Segment.